Institute for Stem Cell Biology and Regenerative Medicine, Stanford Cancer Center, and Ludwig Center at Stanford, USA.
Trends Immunol. 2010 Jun;31(6):212-9. doi: 10.1016/j.it.2010.04.001. Epub 2010 May 7.
Tumor immunosurveillance is a well-established mechanism for regulation of tumor growth. In this regard, most studies have focused on the role of T- and NK-cells as the critical immune effector cells. However, macrophages play a major role in the recognition and clearance of foreign, aged, and damaged cells. Macrophage phagocytosis is negatively regulated via the receptor SIRPalpha upon binding to CD47, a ubiquitously expressed protein. We recently showed that CD47 is up-regulated in myeloid leukemia and migrating hematopoietic progenitors, and that the level of protein expression correlates with the ability to evade phagocytosis. These results implicate macrophages in the immunosurveillance of hematopoietic cells and leukemias. The ability of macrophages to phagocytose tumor cells might be exploited therapeutically by blocking the CD47-SIRPalpha interaction.
肿瘤免疫监视是调节肿瘤生长的一种成熟机制。在这方面,大多数研究都集中在 T 细胞和自然杀伤 (NK) 细胞作为关键免疫效应细胞的作用上。然而,巨噬细胞在识别和清除外来、衰老和受损细胞方面发挥着重要作用。巨噬细胞的吞噬作用通过受体 SIRPalpha 与广泛表达的蛋白 CD47 结合而受到负调控。我们最近发现,CD47 在髓性白血病和迁移造血祖细胞中上调,并且蛋白表达水平与逃避吞噬作用的能力相关。这些结果表明巨噬细胞参与了造血细胞和白血病的免疫监视。通过阻断 CD47-SIRPalpha 相互作用,巨噬细胞吞噬肿瘤细胞的能力可能在治疗上得到利用。